583 related articles for article (PubMed ID: 16990566)
1. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
Chapados R; Abe K; Ihida-Stansbury K; McKean D; Gates AT; Kern M; Merklinger S; Elliott J; Plant A; Shimokawa H; Jones PL
Circ Res; 2006 Oct; 99(8):837-44. PubMed ID: 16990566
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
Liu Y; Suzuki YJ; Day RM; Fanburg BL
Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.
Jones PL; Crack J; Rabinovitch M
J Cell Biol; 1997 Oct; 139(1):279-93. PubMed ID: 9314546
[TBL] [Abstract][Full Text] [Related]
5. Type VIII collagen signals via β1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration.
Adiguzel E; Hou G; Sabatini PJ; Bendeck MP
Matrix Biol; 2013 Aug; 32(6):332-41. PubMed ID: 23523587
[TBL] [Abstract][Full Text] [Related]
6. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis.
Cowan KN; Jones PL; Rabinovitch M
Circ Res; 1999 May; 84(10):1223-33. PubMed ID: 10347097
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
Ihida-Stansbury K; McKean DM; Lane KB; Loyd JE; Wheeler LA; Morrell NW; Jones PL
Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L694-702. PubMed ID: 16782755
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibitors block activation of pancreatic stellate cells.
Masamune A; Kikuta K; Satoh M; Satoh K; Shimosegawa T
Br J Pharmacol; 2003 Dec; 140(7):1292-302. PubMed ID: 14581180
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
11. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease.
Jones FS; Meech R; Edelman DB; Oakey RJ; Jones PL
Circ Res; 2001 Jul; 89(2):131-8. PubMed ID: 11463719
[TBL] [Abstract][Full Text] [Related]
12. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1747-56. PubMed ID: 17379756
[TBL] [Abstract][Full Text] [Related]
13. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
14. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Rho-kinase inhibition on artery wall mass and remodeling.
Pearce JD; Li J; Edwards MS; English WP; Geary RL
J Vasc Surg; 2004 Jan; 39(1):223-8. PubMed ID: 14718843
[TBL] [Abstract][Full Text] [Related]
16. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
17. Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element.
Jones PL; Jones FS; Zhou B; Rabinovitch M
J Cell Sci; 1999 Feb; 112 ( Pt 4)():435-45. PubMed ID: 9914156
[TBL] [Abstract][Full Text] [Related]
18. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain.
Sarasa-Renedo A; Tunç-Civelek V; Chiquet M
Exp Cell Res; 2006 May; 312(8):1361-70. PubMed ID: 16448650
[TBL] [Abstract][Full Text] [Related]
19. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
Smith PC; Cáceres M; Martinez J
J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
[TBL] [Abstract][Full Text] [Related]
20. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
Fukushima M; Nakamuta M; Kohjima M; Kotoh K; Enjoji M; Kobayashi N; Nawata H
Liver Int; 2005 Aug; 25(4):829-38. PubMed ID: 15998434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
